EA200500643A1 - Способ неконкурентного иммуноанализа для определения малых аналитов - Google Patents
Способ неконкурентного иммуноанализа для определения малых аналитовInfo
- Publication number
- EA200500643A1 EA200500643A1 EA200500643A EA200500643A EA200500643A1 EA 200500643 A1 EA200500643 A1 EA 200500643A1 EA 200500643 A EA200500643 A EA 200500643A EA 200500643 A EA200500643 A EA 200500643A EA 200500643 A1 EA200500643 A1 EA 200500643A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- analyte
- unconcurent
- small analytes
- determine small
- binding partner
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9486—Analgesics, e.g. opiates, aspirine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
- G01N2470/04—Sandwich assay format
- G01N2470/06—Second binding partner specifically binding complex of analyte with first binding partner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Wrappers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20022048A FI20022048A0 (fi) | 2002-11-18 | 2002-11-18 | Ei-kompetetiivinen immunomääritys pienille analyyteille |
| PCT/FI2003/000875 WO2004046733A1 (en) | 2002-11-18 | 2003-11-17 | Non-competitive immunoassay for small analytes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200500643A1 true EA200500643A1 (ru) | 2005-12-29 |
Family
ID=8564953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200500643A EA200500643A1 (ru) | 2002-11-18 | 2003-11-17 | Способ неконкурентного иммуноанализа для определения малых аналитов |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7749712B2 (pt) |
| EP (1) | EP1579222B8 (pt) |
| JP (1) | JP4729701B2 (pt) |
| CN (1) | CN1711476B (pt) |
| AT (1) | ATE408146T1 (pt) |
| BR (1) | BRPI0316384B8 (pt) |
| CA (1) | CA2503509C (pt) |
| DE (1) | DE60323538D1 (pt) |
| DK (1) | DK1579222T3 (pt) |
| EA (1) | EA200500643A1 (pt) |
| ES (1) | ES2312828T3 (pt) |
| FI (1) | FI20022048A0 (pt) |
| MX (1) | MXPA05005288A (pt) |
| NO (1) | NO338417B1 (pt) |
| NZ (1) | NZ539714A (pt) |
| WO (1) | WO2004046733A1 (pt) |
| ZA (1) | ZA200503475B (pt) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030109067A1 (en) | 2001-12-06 | 2003-06-12 | Immunetech, Inc. | Homogeneous immunoassays for multiple allergens |
| JP2007040834A (ja) * | 2005-08-03 | 2007-02-15 | Japan Science & Technology Agency | 免疫測定用試薬 |
| FI20075251A0 (fi) * | 2007-04-13 | 2007-04-13 | Hytest Oy | Immunomääritys epästabiilien antigeenien määrittämiseksi |
| GB0707870D0 (en) * | 2007-04-23 | 2007-05-30 | Selected Antibodies Ltd | Assay Devices and Methods and Components for use Therein |
| ATE522816T1 (de) * | 2007-12-18 | 2011-09-15 | Inst Nat Sante Rech Med | Endogenes morphin oder natürlich vorkommender metabolit davon als marker für sepsis |
| GB0725234D0 (en) * | 2007-12-24 | 2008-02-06 | Oxtex Ltd | Electrochemical assays |
| US9057723B2 (en) * | 2008-04-02 | 2015-06-16 | Vivacta Ltd. | Method for sensing a chemical |
| US8093018B2 (en) * | 2008-05-20 | 2012-01-10 | Otsuka Pharmaceutical Co., Ltd. | Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same |
| FI20085579A0 (fi) * | 2008-06-12 | 2008-06-12 | Valtion Teknillinen | Kannabiskäytön toteaminen |
| DE102008049601A1 (de) * | 2008-09-30 | 2010-04-01 | Siemens Healthcare Diagnostics Products Gmbh | Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay |
| US9476891B2 (en) | 2009-07-21 | 2016-10-25 | Sekisui Medical Co., Ltd. | Insulin assay |
| CN102639150A (zh) * | 2009-10-30 | 2012-08-15 | 默沙东公司 | Ax213和ax132 pcsk9拮抗剂和变体 |
| EP2515110B1 (en) * | 2009-11-19 | 2015-03-25 | Ushio Denki Kabushiki Kaisha | Fluoroimmunoassay method |
| US8883978B2 (en) | 2010-05-11 | 2014-11-11 | Institute For Cancer Research | Antibodies to tumor endothelial marker 7R |
| EP2759551B1 (en) * | 2011-09-21 | 2019-05-22 | Fujirebio Inc. | Antibodies binding to an affinity complex comprising 25oh vitamin d2 or d3 and an antibody thereto |
| CA2853103C (en) * | 2011-10-21 | 2020-01-07 | Decimadx, Llc | Point-of-care immunoassay for quantitative small analyte detection |
| EP2637021A1 (de) | 2012-03-06 | 2013-09-11 | Securetec Detektions-Systeme AG | Verfahren und Vorrichtung zum Nachweis von Analyten |
| US9804161B1 (en) | 2012-05-14 | 2017-10-31 | Lawrence Livermore National Security, Llc | Detector and related, devices, methods and systems |
| EP2722669A1 (de) | 2012-10-22 | 2014-04-23 | Securetec Detektions-Systeme AG | Verfahren und Vorrichtung zum Nachweis von illegalen Drogen |
| JP6673895B2 (ja) | 2014-03-21 | 2020-03-25 | エスティー アンド ティー インターナショナル，インコーポレイティド | アサ属抽出方法及び組成物 |
| FI126746B (en) | 2014-04-07 | 2017-05-15 | Teknologian Tutkimuskeskus Vtt Oy | Antibody to HT-2 toxin-HT-2 toxin antibody complex |
| WO2017053567A1 (en) * | 2015-09-22 | 2017-03-30 | Delta Tm Technologies | Designing customized protein-specific buffer systems |
| EP3365442B8 (en) * | 2015-10-23 | 2022-06-08 | Fred Hutchinson Cancer Center | Methods to create chemically-induced dimerizing protein systems for regulation of cellular events |
| CA3047691C (en) | 2015-12-21 | 2022-12-06 | Turun Yliopisto | Antibodies against immunocomplexes comprising cyanobacterial cyclic peptide hepatotoxins |
| WO2017127833A1 (en) * | 2016-01-22 | 2017-07-27 | Affimedix, Inc. | Device for detection of vitamin d metabolites |
| CA3031355C (en) * | 2016-07-29 | 2023-05-23 | Diazyme Laboratories, Inc. | Methods and compositions for assaying vitamin d |
| AU2020413304A1 (en) | 2019-12-27 | 2022-07-14 | Chiome Bioscience Inc. | Anti-CDCP1 antibody |
| EP4215211A1 (en) | 2020-09-02 | 2023-07-26 | The University of Tokyo | Tumor immune microenvironment regulator, and preventive, diagnostic or therapeutic use thereof |
| WO2023102201A2 (en) * | 2021-12-03 | 2023-06-08 | University Of Utah Research Foundation | High selective cd229 antigen binding domains and methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3996345A (en) * | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US5223441A (en) | 1986-10-09 | 1993-06-29 | Syntex (U.S.A.) Inc. | Receptors for immune complexes |
| EP0759976A4 (en) | 1994-03-30 | 2001-02-07 | Igen Int Inc | THE INSULATION AND PRODUCTION OF CATALYTIC ANTIBODIES USING PHAGENTECHNOLOGY |
| JP3025633B2 (ja) | 1995-12-05 | 2000-03-27 | 株式会社蛋白工学研究所 | グルタチオン結合活性を有するポリペプチド及びその製造方法 |
| JP4228095B2 (ja) * | 1999-12-17 | 2009-02-25 | 東ソー株式会社 | 免疫測定方法および免疫測定試薬 |
| CN1136450C (zh) * | 2000-11-03 | 2004-01-28 | 厦门大学 | 具有荧光共振能量转移特征的成对蛋白及其用途 |
-
2002
- 2002-11-18 FI FI20022048A patent/FI20022048A0/fi unknown
-
2003
- 2003-11-17 DE DE60323538T patent/DE60323538D1/de not_active Expired - Lifetime
- 2003-11-17 NZ NZ539714A patent/NZ539714A/en not_active IP Right Cessation
- 2003-11-17 EA EA200500643A patent/EA200500643A1/ru unknown
- 2003-11-17 WO PCT/FI2003/000875 patent/WO2004046733A1/en active IP Right Grant
- 2003-11-17 DK DK03773761T patent/DK1579222T3/da active
- 2003-11-17 JP JP2004552756A patent/JP4729701B2/ja not_active Expired - Lifetime
- 2003-11-17 US US10/535,260 patent/US7749712B2/en active Active
- 2003-11-17 EP EP03773761A patent/EP1579222B8/en not_active Expired - Lifetime
- 2003-11-17 ES ES03773761T patent/ES2312828T3/es not_active Expired - Lifetime
- 2003-11-17 CN CN2003801034664A patent/CN1711476B/zh not_active Expired - Lifetime
- 2003-11-17 MX MXPA05005288A patent/MXPA05005288A/es active IP Right Grant
- 2003-11-17 AT AT03773761T patent/ATE408146T1/de not_active IP Right Cessation
- 2003-11-17 CA CA2503509A patent/CA2503509C/en not_active Expired - Lifetime
- 2003-11-17 BR BRPI0316384A patent/BRPI0316384B8/pt active IP Right Grant
-
2005
- 2005-04-29 ZA ZA200503475A patent/ZA200503475B/en unknown
- 2005-06-13 NO NO20052849A patent/NO338417B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1711476A (zh) | 2005-12-21 |
| ES2312828T3 (es) | 2009-03-01 |
| NO338417B1 (no) | 2016-08-15 |
| CA2503509A1 (en) | 2004-06-03 |
| NO20052849L (no) | 2005-06-13 |
| CA2503509C (en) | 2013-02-05 |
| AU2003282143A1 (en) | 2004-06-15 |
| JP2006506634A (ja) | 2006-02-23 |
| DK1579222T3 (da) | 2008-11-17 |
| ZA200503475B (en) | 2006-07-26 |
| EP1579222B1 (en) | 2008-09-10 |
| US7749712B2 (en) | 2010-07-06 |
| BR0316384A (pt) | 2005-10-04 |
| BRPI0316384B8 (pt) | 2021-07-27 |
| WO2004046733A1 (en) | 2004-06-03 |
| FI20022048A0 (fi) | 2002-11-18 |
| EP1579222A1 (en) | 2005-09-28 |
| DE60323538D1 (de) | 2008-10-23 |
| NZ539714A (en) | 2007-03-30 |
| CN1711476B (zh) | 2010-09-08 |
| US20060246506A1 (en) | 2006-11-02 |
| BRPI0316384B1 (pt) | 2016-07-05 |
| JP4729701B2 (ja) | 2011-07-20 |
| MXPA05005288A (es) | 2005-08-16 |
| ATE408146T1 (de) | 2008-09-15 |
| EP1579222B8 (en) | 2009-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200500643A1 (ru) | Способ неконкурентного иммуноанализа для определения малых аналитов | |
| WO2002090983A3 (de) | Quantitaver einschritt immuntest in lyophilisierter form | |
| ATE333649T1 (de) | Immunotestverfahren für herz-troponin i | |
| ATE457459T1 (de) | Homogene immunoassays für mehrere allergene | |
| ATE432947T1 (de) | Menschliche antikörper als detektionsreagenzien | |
| DE60116172D1 (de) | Immunoassay für C-reaktives Protein | |
| ATE487946T1 (de) | Analytischer sandwichtest zur bestimmung von nt- probnp | |
| ATE447712T1 (de) | Immunoassay mit doppelter standardkurve | |
| ATE374944T1 (de) | Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung | |
| ATE310956T1 (de) | Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie | |
| NO20052870D0 (no) | Immunoanalysemetode og sett for anvendelse derav | |
| EP1072888A3 (en) | Immunoassay method and reagent for HIV-1p24 antigen | |
| DE50306501D1 (de) | Verfahren zur quantitativen bestimmung mehrerer analyten | |
| EP1347298A3 (en) | Immunoassay method, test strip for use therein, and immunoassay apparatus | |
| EP1245957A3 (en) | Method of measuring ceruloplasmin concentration with enzyme-linked immunosorbent assay or dissociation-enhanced time-resolved fluoroimmunoassay in a blood spot, and Wilson's disease screening kit and method of diagnosing Wilson's disease | |
| ATE466884T1 (de) | Holo-transcobalamin bindungspartner und ihre verwendung in cobalamintest | |
| WO2001063285A3 (de) | Verfahren zum nachweis von helicobacter pylori und heilmanii | |
| ATE108907T1 (de) | Bestimmungsverfahren, seine verwendung und komponenten. | |
| Kergaravat et al. | Magneto immunofluorescence assay for diagnosis of celiac disease | |
| NO903820L (no) | Fremgangsmaate for paavisning av analytter. | |
| CA2513271A1 (en) | Generic method for latex agglutination assays | |
| FR2807438B1 (fr) | Nouveaux anticorps reconnaissant specifiquement le psa libre inactif, et leurs applications | |
| SE9303272D0 (sv) | Improvement in immunoassays |